GARBARINO, OMBRETTA
GARBARINO, OMBRETTA
100006 - Dipartimento di Farmacia
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
2020-01-01 Marengo, B.; Meta, E.; Brullo, C.; de Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C.
CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects
2019-01-01 Monteleone, L; Speciale, A; Traverso, N; Garbarino, O; Ravera, S; Domenicotti, C; Marengo, B
Characterization of metabolic and molecular response of a human melanoma cell line resistant to PLX4032
2019-01-01 Garbarino, O; Marengo, B; Monteleone, L; Pietra, G; Ravera, S; Passalacqua, M; Bruzzone, S; Domenicotti, C
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget)
2023-01-01 Marengo, B.; Meta, E.; Brullo, C.; Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C.
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
2018-01-01 Marengo, Barbara; Monti, Paola; Miele, Mariangela; Menichini, Paola; Ottaggio, Laura; Foggetti, Giorgia; Pulliero, Alessandra; Izzotti, Alberto; Speciale, Andrea; Garbarino, Ombretta; Traverso, Nicola; Fronza, Gilberto; Domenicotti, Cinzia
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma
2017-01-01 Domenicotti, CINZIA MARIA; Speciale, Andrea; Garbarino, Ombretta; Izzotti, Alberto; Fenoglio, Daniela; Ravera, Silvia; Pulliero, Alessandra; Passalacqua, Mario; Traverso, Nicola; Pronzato, MARIA ADELAIDE; Marengo, Barbara
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
2019-01-01 Marengo, Barbara; Garbarino, Ombretta; Speciale, Andrea; Monteleone, Lorenzo; Traverso, Nicola; Domenicotti, Cinzia
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis
2021-01-01 Monteleone, L.; Speciale, A.; Valenti, G. E.; Traverso, N.; Ravera, S.; Garbarino, O.; Leardi, R.; Farinini, E.; Roveri, A.; Ursini, F.; Cantoni, C.; Pronzato, M. A.; Marinari, U. M.; Marengo, B.; Domenicotti, C.
PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism
2023-01-01 Garbarino, Ombretta; Valenti, Giulia Elda; Monteleone, Lorenzo; Pietra, Gabriella; Mingari, Maria Cristina; Benzi, Andrea; Bruzzone, Santina; Ravera, Silvia; Leardi, Riccardo; Farinini, Emanuele; Vernazza, Stefania; Grottoli, Melania; Marengo, Barbara; Domenicotti, Cinzia
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide
2018-01-01 Speciale, Andrea; Marengo, Barbara; Traverso, Nicola; Cantoni, Claudia; Ravera, Silvia; Garbarino, Ombretta; Pronzato, Maria Adelaide; Domenicotti, Cinzia
xCT/CD44 modulation induces the sensitization of neuroblastoma-stem cells to etoposide.
2018-01-01 Speciale, A; Marengo, B; Traverso, N; Monteleone, L; Cantoni, C; Ravera, S; Garbarino, O; Pronzato, Ma; Domenicotti, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma | 1-gen-2020 | Marengo, B.; Meta, E.; Brullo, C.; de Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C. | |
| CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects | 1-gen-2019 | Monteleone, L; Speciale, A; Traverso, N; Garbarino, O; Ravera, S; Domenicotti, C; Marengo, B | |
| Characterization of metabolic and molecular response of a human melanoma cell line resistant to PLX4032 | 1-gen-2019 | Garbarino, O; Marengo, B; Monteleone, L; Pietra, G; Ravera, S; Passalacqua, M; Bruzzone, S; Domenicotti, C | |
| Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) | 1-gen-2023 | Marengo, B.; Meta, E.; Brullo, C.; Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C. | |
| Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation | 1-gen-2018 | Marengo, Barbara; Monti, Paola; Miele, Mariangela; Menichini, Paola; Ottaggio, Laura; Foggetti, Giorgia; Pulliero, Alessandra; Izzotti, Alberto; Speciale, Andrea; Garbarino, Ombretta; Traverso, Nicola; Fronza, Gilberto; Domenicotti, Cinzia | |
| Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma | 1-gen-2017 | Domenicotti, CINZIA MARIA; Speciale, Andrea; Garbarino, Ombretta; Izzotti, Alberto; Fenoglio, Daniela; Ravera, Silvia; Pulliero, Alessandra; Passalacqua, Mario; Traverso, Nicola; Pronzato, MARIA ADELAIDE; Marengo, Barbara | |
| MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance | 1-gen-2019 | Marengo, Barbara; Garbarino, Ombretta; Speciale, Andrea; Monteleone, Lorenzo; Traverso, Nicola; Domenicotti, Cinzia | |
| Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis | 1-gen-2021 | Monteleone, L.; Speciale, A.; Valenti, G. E.; Traverso, N.; Ravera, S.; Garbarino, O.; Leardi, R.; Farinini, E.; Roveri, A.; Ursini, F.; Cantoni, C.; Pronzato, M. A.; Marinari, U. M.; Marengo, B.; Domenicotti, C. | |
| PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism | 1-gen-2023 | Garbarino, Ombretta; Valenti, Giulia Elda; Monteleone, Lorenzo; Pietra, Gabriella; Mingari, Maria Cristina; Benzi, Andrea; Bruzzone, Santina; Ravera, Silvia; Leardi, Riccardo; Farinini, Emanuele; Vernazza, Stefania; Grottoli, Melania; Marengo, Barbara; Domenicotti, Cinzia | |
| Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide | 1-gen-2018 | Speciale, Andrea; Marengo, Barbara; Traverso, Nicola; Cantoni, Claudia; Ravera, Silvia; Garbarino, Ombretta; Pronzato, Maria Adelaide; Domenicotti, Cinzia | |
| xCT/CD44 modulation induces the sensitization of neuroblastoma-stem cells to etoposide. | 1-gen-2018 | Speciale, A; Marengo, B; Traverso, N; Monteleone, L; Cantoni, C; Ravera, S; Garbarino, O; Pronzato, Ma; Domenicotti, C. |